Tweet
- HEALTH REPORTER
The Globe and Mail
Published <time datetime="2014-43-28T16:08:15Z" pubdate="">Thursday, Aug. 28 2014, 12:43 PM EDT</time>
Human trials of Canada?s experimental Ebola vaccine are expected to start in the United States this fall, but, like other vaccine candidates headed for accelerated testing in humans, the Canadian-developed injection will not be deployed to the West African outbreak until next year at the earliest.
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced Thursday that it would begin next week enrolling healthy adult volunteers in a phase I trial of a different vaccine, developed in partnership with the pharmaceutical giant GlaxoSmithKline, Inc., and based on a chimpanzee cold virus....
http://www.theglobeandmail.com/life/...ticle20234961/
The Globe and Mail
Published <time datetime="2014-43-28T16:08:15Z" pubdate="">Thursday, Aug. 28 2014, 12:43 PM EDT</time>
Human trials of Canada?s experimental Ebola vaccine are expected to start in the United States this fall, but, like other vaccine candidates headed for accelerated testing in humans, the Canadian-developed injection will not be deployed to the West African outbreak until next year at the earliest.
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced Thursday that it would begin next week enrolling healthy adult volunteers in a phase I trial of a different vaccine, developed in partnership with the pharmaceutical giant GlaxoSmithKline, Inc., and based on a chimpanzee cold virus....
http://www.theglobeandmail.com/life/...ticle20234961/
